Palatin Technologies
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 8/5/2024
Pipeline by Phase
Therapeutic Focus
Clinical Trials (9)
A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye
Started: 12/30/2021
1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
Started: 12/1/2014
2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
Started: 1/1/2015
Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects
Started: 11/12/2020
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Started: 8/5/2024
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
Started: 9/15/2022
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Started: 12/26/2022
Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
Started: 6/1/2011
Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension
Started: 4/1/2008